PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAC Immune SA
AC Immune SA(ACIU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
multiple myeloma
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
,
prostatic neoplasms
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
recurrence
Gilvetmab
hodgkin disease
Bevifimod
liver diseases
,
hyponatremia
,
gram-positive bacterial infections
,
kidney diseases
,
wound infection
,
abscess
,
ulcer
,
burns
,
cellulitis
,
emergencies
,
staphylococcal infections
,
bacterial pneumonia
,
staphylococcal skin infections
,
bacteremia
,
drug overdose
,
healthcare-associated pneumonia
,
mental disorders
,
autistic disorder
Fludeoxyglucose f-18
parkinson disease
,
neurodegenerative diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use